Rosana Hernandez-Antolin

Showing 1-3 of 3 articles

Coronary interventions

Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-Segment Elevation Myocardial Infarction: vascular healing outcomes from the MAGSTEMI trial

Gomez-Lara J, Ortega-Paz L, Brugaletta S, Cuesta J, Romaní S, Serra A, Salinas P, García del Blanco B, Goicolea J, Hernandez-Antolin R, Antuna P, Romaguera R, Regueiro A, Rivero F, Cequier A, Alfonso F, Gomez-Hospital J, Sabate M, Freixa X, Masotti M, Ferreiro JL, Roura G, Bastante T, Jiménez M, Otaegui I, Bordes P, Iñiguez A

April 21, 2020 | 10.4244/EIJ-D-20-00198

Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy

Asano T, Katagiri Y, Collet C, Tenekecioglu E, Miyazaki Y, Sotomi Y, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernandez-Antolin R, van de Harst P, Iñiguez A, Janssens L, Smits P, Wykrzykowska J, Ribeiro V, Pereira H, da Silva P, Piek J, Reiber J, von Birgelen C, Sabate M, Onuma Y, Serruys P

August 3, 2018 | 10.4244/EIJ-D-17-00461

Is refined OCT guidance of stent implantation needed?

Gonzalo N, Escaned J, Alfonso F, Quevedo P, Zakhem B, Banuelos C, Hernandez-Antolin R, Macaya C

May 25, 2010

1

Latest news

Atherectomies, in-stent restenosis, stent thrombosis, coronary physiology in TAVI and heart failure

Ahead of print: New technique of percutaneous mitral valvuloplasty

C. Aurigemma et al

Rotational atherectomy and the myth of Sisyphus

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

(The Trials book is supported by Biotronik)

Guidance Papers

Guidelines, consensus & position papers

Fractional flow reserve substitutes in aortic stenosis

Nils P. Johnson

This Week's JAA's: Real-world Use of the Evolut PRO Valve...

Valvular disease